{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:19:02Z","timestamp":1759331942450},"reference-count":49,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,27]],"date-time":"2023-02-27T00:00:00Z","timestamp":1677456000000},"content-version":"vor","delay-in-days":6085,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Clinical Nutrition"],"published-print":{"date-parts":[[2006,7]]},"DOI":"10.1093\/ajcn\/84.1.204","type":"journal-article","created":{"date-parts":[[2018,2,16]],"date-time":"2018-02-16T23:54:11Z","timestamp":1518825251000},"page":"204-211","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Physiologic growth hormone replacement improves fasting lipid kinetics in patients with HIV lipodystrophy syndrome"],"prefix":"10.1016","volume":"84","author":[{"given":"Susana","family":"D\u2019Amico","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianjian","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajagopal V","family":"Sekhar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farook","family":"Jahoor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth J","family":"Ellis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khaleel","family":"Rehman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Willis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Maldonado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashok","family":"Balasubramanyam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1093\/ajcn\/84.1.204_bib1","doi-asserted-by":"crossref","first-page":"F51","DOI":"10.1097\/00002030-199807000-00003","article-title":"A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors","volume":"12","author":"Carr","year":"1998","journal-title":"AIDS"},{"key":"10.1093\/ajcn\/84.1.204_bib2","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1097\/00002030-200305230-00010","article-title":"Cardiovascular disease risk factors in HIV patients: association with antiretroviral therapy. Results from the DAD study","volume":"17","author":"Friis-Moller","year":"2003","journal-title":"AIDS"},{"key":"10.1093\/ajcn\/84.1.204_bib3","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1097\/00002030-200409030-00010","article-title":"Cardio- and cerebrovascular events in HIV-infected persons","volume":"18","author":"d\u2019Arminio","year":"2004","journal-title":"AIDS"},{"key":"10.1093\/ajcn\/84.1.204_bib4","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1097\/00002030-200311210-00010","article-title":"Increased risk of myocardial infarction with duration of protease inhibitor therapy in HIV-infected men","volume":"17","author":"Mary-Krause","year":"2003","journal-title":"AIDS"},{"key":"10.1093\/ajcn\/84.1.204_bib5","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ahj.2003.07.007","article-title":"Acute myocardial infarction in patients infected with human immunodeficiency virus","volume":"147","author":"Varriale","year":"2004","journal-title":"Am Heart J"},{"key":"10.1093\/ajcn\/84.1.204_bib6","first-page":"504","article-title":"Assessment of growth hormone dynamics in human immunodeficiency virus-related lipodystrophy","volume":"86","author":"Rietschel","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1093\/ajcn\/84.1.204_bib7","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1210\/jc.2004-1342","article-title":"Growth hormone (GH) responses to GH-releasing hormone-arginine testing in human immunodeficiency virus lipodystrophy","volume":"90","author":"Koutkia","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1093\/ajcn\/84.1.204_bib8","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1097\/00002030-199910220-00013","article-title":"Recombinant human growth hormone improves the fat redistribution syndrome (lipodystrophy) in patients with HIV","volume":"13","author":"Wanke","year":"1999","journal-title":"AIDS"},{"key":"10.1093\/ajcn\/84.1.204_bib9","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1210\/jcem.86.8.7879","article-title":"The rational use of growth hormone in HIV-infected patients","volume":"86","author":"Grinspoon","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1093\/ajcn\/84.1.204_bib10","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1097\/00002030-200307040-00003","article-title":"Impaired growth hormone secretion correlates with visceral adiposity in highly active antiretroviral treated HIV-infected adolescents","volume":"17","author":"Vigano","year":"2003","journal-title":"AIDS"},{"key":"10.1093\/ajcn\/84.1.204_bib11","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/00042560-200208010-00002","article-title":"Effect of recombinant human growth hormone in the treatment of visceral fat accumulation in HIV infection","volume":"30","author":"Engelson","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1093\/ajcn\/84.1.204_bib12","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1152\/japplphysiol.00845.2002","article-title":"Preferential loss of omental-mesenteric fat during growth hormone therapy of HIV-associated lipodystrophy","volume":"94","author":"He","year":"2003","journal-title":"J Appl Physiol"},{"key":"10.1093\/ajcn\/84.1.204_bib13","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/00126334-200403010-00004","article-title":"Effects of growth hormone on abnormal visceral adipose tissue accumulation and dyslipidemia in HIV-infected patients","volume":"35","author":"Kotler","year":"2004","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1093\/ajcn\/84.1.204_bib14","doi-asserted-by":"crossref","first-page":"873","DOI":"10.7326\/0003-4819-125-11-199612010-00002","article-title":"Recombinant human growth hormone in patients with HIV-associated wasting. A randomized, placebo-controlled trial","volume":"125","author":"Schambelan","year":"1996","journal-title":"Serostim Study Group Ann Intern Med"},{"key":"10.1093\/ajcn\/84.1.204_bib15","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1001\/jama.292.2.210","article-title":"Growth hormone-releasing hormone in HIV-infected men with lipodystrophy: a randomized controlled trial","volume":"292","author":"Koutkia","year":"2004","journal-title":"JAMA"},{"key":"10.1093\/ajcn\/84.1.204_bib16","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/j.1365-2362.2004.01380.x","article-title":"Low-dose growth hormone and human immunodeficiency virus-associated lipodystrophy syndrome: a pilot study","volume":"34","author":"Andersen","year":"2004","journal-title":"Eur J Clin Invest"},{"key":"10.1093\/ajcn\/84.1.204_bib17","doi-asserted-by":"crossref","first-page":"E332","DOI":"10.1152\/ajpendo.00058.2002","article-title":"Metabolic basis of HIV-lipodystrophy syndrome","volume":"283","author":"Sekhar","year":"2002","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1093\/ajcn\/84.1.204_bib18","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1053\/meta.2002.34704","article-title":"Increased rates of lipolysis among human immunodeficiency virus-infected men receiving highly active antiretroviral therapy","volume":"51","author":"Hadigan","year":"2002","journal-title":"Metabolism"},{"key":"10.1093\/ajcn\/84.1.204_bib19","doi-asserted-by":"crossref","first-page":"E490","DOI":"10.1152\/ajpendo.00118.2003","article-title":"Alterations in lipid kinetics in men with HIV-dyslipidemia","volume":"285","author":"Reeds","year":"2003","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1093\/ajcn\/84.1.204_bib20","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/00002030-200001070-00005","article-title":"Fat distribution evaluated by computed tomography and metabolic abnormalities in patients undergoing antiretroviral therapy: preliminary results of the LIPOCO study","volume":"14","author":"Saint-Marc","year":"2000","journal-title":"AIDS"},{"key":"10.1093\/ajcn\/84.1.204_bib21","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1097\/00126334-200308150-00004","article-title":"An objective lipodystrophy severity grading scale derived from the lipodystrophy case definition score","volume":"33","author":"Carr","year":"2003","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1093\/ajcn\/84.1.204_bib22","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"10.1093\/ajcn\/84.1.204_bib23","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.2337\/diacare.22.9.1462","article-title":"Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp","volume":"22","author":"Matsuda","year":"1999","journal-title":"Diabetes Care"},{"key":"10.1093\/ajcn\/84.1.204_bib24","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1093\/jn\/128.9.1517","article-title":"Dietary amino acids are the preferential source of hepatic protein synthesis in piglets","volume":"128","author":"Stoll","year":"1998","journal-title":"J Nutr"},{"key":"10.1093\/ajcn\/84.1.204_bib25","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/0003-2697(92)90595-X","article-title":"A mass spectrometric method for measuring glycerol levels and enrichments in plasma using13C and2H stable isotopic tracers","volume":"205","author":"Gilker","year":"1992","journal-title":"Anal Biochem"},{"key":"10.1093\/ajcn\/84.1.204_bib26","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1021\/ac00009a017","article-title":"Isotopic determination of organic keto acid pentafluorobenzyl esters in biological fluids by negative chemical ionization gas chromatography\/mass spectrometry","volume":"63","author":"Hachey","year":"1991","journal-title":"Anal Chem"},{"key":"10.1093\/ajcn\/84.1.204_bib27","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/S0022-2275(20)37908-6","article-title":"Isopropanol precipitation method for the determination of apolipoprotein B specific activity and plasma concentrations during metabolic studies of very low density lipoprotein and low density lipoprotein apolipoprotein B","volume":"24","author":"Egusa","year":"1983","journal-title":"J Lipid Res"},{"key":"10.1093\/ajcn\/84.1.204_bib28","first-page":"R221","article-title":"Measurement of plasma protein synthesis rate in infant pig: an investigation of alternative tracer approaches","volume":"267","author":"Jahoor","year":"1994","journal-title":"Am J Physiol"},{"key":"10.1093\/ajcn\/84.1.204_bib29","first-page":"E649","article-title":"A new correction factor for use in tracer estimations of plasma fatty acid oxidation","volume":"269","author":"Sidossis","year":"1995","journal-title":"Am J Physiol"},{"key":"10.1093\/ajcn\/84.1.204_bib30","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1152\/jappl.1983.55.2.628","article-title":"Calculation of substrate oxidation rates in vivo from gaseous exchange","volume":"55","author":"Frayn","year":"1983","journal-title":"J Appl Physiol"},{"key":"10.1093\/ajcn\/84.1.204_bib31","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1016\/S0022-2275(20)42353-3","article-title":"Comparison of deuterated leucine, valine, and lysine in the measurement of human apolipoprotein A-I and B-100 kinetics","volume":"31","author":"Lichtenstein","year":"1990","journal-title":"J Lipid Res"},{"key":"10.1093\/ajcn\/84.1.204_bib32","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1093\/jn\/122.3.457","article-title":"VLDL apolipoprotein B-100, a potential indicator of the isotopic labeling of the hepatic protein synthetic precursor pool in humans: studies with multiple stable isotopically labeled amino acids","volume":"122","author":"Reeds","year":"1992","journal-title":"J Nutr"},{"key":"10.1093\/ajcn\/84.1.204_bib33","series-title":"Statistical methods.","author":"Snedecor","year":"1980"},{"key":"10.1093\/ajcn\/84.1.204_bib34","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1097\/00002030-199912030-00023","article-title":"Recombinant human growth hormone improves truncal adiposity and \u2018buffalo humps\u2019 in HIV-positive patients on HAART","volume":"13","author":"Torres","year":"1999","journal-title":"AIDS"},{"key":"10.1093\/ajcn\/84.1.204_bib35","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1086\/343051","article-title":"Effects of recombinant human growth hormone on fat distribution in patients with human immunodeficiency virus-associated wasting","volume":"35","author":"Tai","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1093\/ajcn\/84.1.204_bib36","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0899-9007(02)00760-8","article-title":"Weight-losing HIV-infected patients on recombinant human growth hormone for 12 wk: a national study","volume":"18","author":"Cominelli","year":"2002","journal-title":"Nutrition"},{"key":"10.1093\/ajcn\/84.1.204_bib37","first-page":"1542","article-title":"Effects of chronic growth hormone treatment on energy intake and resting energy metabolism in patients with human immunodeficiency virus-associated wasting: a clinical research center study","volume":"83","author":"Mulligan","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1093\/ajcn\/84.1.204_bib38","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1210\/jcem.87.2.8391","article-title":"Effects of recombinant human growth hormone on hepatic lipid and carbohydrate metabolism in HIV-infected patients with fat accumulation","volume":"87","author":"Schwarz","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1093\/ajcn\/84.1.204_bib39","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1210\/jcem.83.2.4545","article-title":"A dose-response study of growth hormone (GH) replacement on whole body protein and lipid kinetics in GH-deficient adults","volume":"83","author":"Lucidi","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1093\/ajcn\/84.1.204_bib40","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1210\/jcem.87.7.8590","article-title":"Short-term treatment with low doses of recombinant human GH stimulates lipolysis in visceral obese men","volume":"87","author":"Lucidi","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1093\/ajcn\/84.1.204_bib41","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1210\/jc.2002-020542","article-title":"Growth hormone replacement therapy induces insulin resistance by activating the glucose-fatty acid cycle","volume":"88","author":"Bramnert","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1093\/ajcn\/84.1.204_bib42","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1086\/422725","article-title":"The effects of low-dose growth hormone in HIV-infected men with fat accumulation: a pilot study","volume":"39","author":"Lo","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1093\/ajcn\/84.1.204_bib43","doi-asserted-by":"crossref","first-page":"E737","DOI":"10.1152\/ajpendo.00092.2003","article-title":"Effects of GH on urea, glucose and lipid metabolism, and insulin sensitivity during fasting in GH-deficient patients","volume":"285","author":"Norrelund","year":"2003","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1093\/ajcn\/84.1.204_bib44","doi-asserted-by":"crossref","first-page":"5827","DOI":"10.1210\/jc.2002-021943","article-title":"Short- and long-term effects of growth hormone (GH) replacement on protein metabolism in GH-deficient adults","volume":"88","author":"Shi","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1093\/ajcn\/84.1.204_bib45","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1210\/endo-115-3-1151","article-title":"The antilipolytic, insulin-like effect of growth hormone is caused by a net decrease of hormone-sensitive lipase phosphorylation","volume":"115","author":"Bjorgell","year":"1984","journal-title":"Endocrinology"},{"key":"10.1093\/ajcn\/84.1.204_bib46","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1210\/jc.2002-021894","article-title":"Low-dose growth hormone inhibits 11 beta-hydroxysteroid dehydrogenase type 1 but has no effect upon fat mass in patients with simple obesity","volume":"88","author":"Tomlinson","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1093\/ajcn\/84.1.204_bib47","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1038\/nm1201-1327","article-title":"HIV protease inhibitors protect apolipoprotein B from degradation by the proteasome: a potential mechanism for protease inhibitor-induced hyperlipidemia","volume":"7","author":"Liang","year":"2001","journal-title":"Nat Med"},{"key":"10.1093\/ajcn\/84.1.204_bib48","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1093\/ajcn\/81.6.1405","article-title":"Severely dysregulated disposal of postprandial triacylglycerols exacerbates hypertriacylglycerolemia in HIV lipodystrophy syndrome","volume":"81","author":"Sekhar","year":"2005","journal-title":"Am J Clin Nutr"},{"key":"10.1093\/ajcn\/84.1.204_bib49","series-title":"Effects of recombinant growth hormone on visceral fat accumulation: pilot study in HIV-infected adolescents. Programme and abstracts, 6th International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV","first-page":"L3","author":"Vigano","year":"2004"}],"container-title":["The American Journal of Clinical Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002916523277928?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002916523277928?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/ajcn\/article-pdf\/84\/1\/204\/24142824\/znu00706000204.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,27]],"date-time":"2023-05-27T12:44:21Z","timestamp":1685191461000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002916523277928"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,7]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,7]]}},"alternative-id":["S0002916523277928"],"URL":"https:\/\/doi.org\/10.1093\/ajcn\/84.1.204","relation":{},"ISSN":["0002-9165"],"issn-type":[{"value":"0002-9165","type":"print"}],"subject":[],"published":{"date-parts":[[2006,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Physiologic growth hormone replacement improves fasting lipid kinetics in patients with HIV lipodystrophy syndrome","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Clinical Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1093\/ajcn\/84.1.204","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 American Society for Nutrition. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}